InChI=1S/C44H78NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-35-37-44(47)53-42(41-52-54(48,49)51-39-38-45(3,4)5)40-50-43(46)36-34-32-30-28-26-24-19-17-15-13-11-9-7-2/h14,16-17,19-21,23,25,29,31,42H,6-13,15,18,22,24,26-28,30,32-41H2,1-5H3/b16-14-,19-17-,21-20-,25-23-,31-29-/t42-/m1/s1 |
DYDDZDMJSQYFGN-OIVUZXIWSA-N |
CCCCCC\C=C/CCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via phosphatidylcholine 36:5 )
|
|
View more via ChEBI Ontology
Outgoing
|
1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84816)
has functional parent
arachidonic acid
(CHEBI:15843)
1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84816)
has functional parent
palmitoleic acid
(CHEBI:28716)
1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84816)
has role
mouse metabolite
(CHEBI:75771)
1-[(9Z)-hexadecenoyl]-2-[(5Z,8Z,11Z,14Z)-eicosatetraenoyl]-sn-glycero-3-phosphocholine
(CHEBI:84816)
is a
phosphatidylcholine 36:5
(CHEBI:64504)
|
|
(2R)-3-[(9Z)-hexadec-9-enoyloxy]-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propyl 2-(trimethylammonio)ethyl phosphate
|
1-Palmitoleoyl-2-arachidonoyl-sn-glycero-3-phosphocholine
|
HMDB
|
13.Phosphatidylcholine(16:1n7/20:4n6)
|
HMDB
|
GPCho(16:1/20:4)
|
HMDB
|
GPCho(16:1n7/20:4n6)
|
HMDB
|
GPCho(16:1w7/20:4w6)
|
HMDB
|
GPCho(36:5)
|
HMDB
|
PC(16:1(9Z)/20:4(5Z,8Z,11Z,14Z))
|
LIPID MAPS
|
PC(16:1/20:4)
|
LIPID MAPS
|
PC(16:1n7/20:4n6)
|
HMDB
|
PC(16:1w7/20:4w6)
|
HMDB
|
Phosphatidylcholine(16:1/20:4)
|
HMDB
|
Phosphatidylcholine(16:1w7/20:4w6)
|
HMDB
|
|